TuHURA Biosciences shares are trading lower. The company announced it filed an IND with the FDA Division of Hematologic Malignancies 1 for the study of TBS-2025 in blood-related cancer treatment.
TuHURA Biosciences, Inc. -2.82%
TuHURA Biosciences, Inc. HURA | 3.06 | -2.82% |
TuHURA Biosciences shares are trading lower. The company announced it filed an IND with the FDA Division of Hematologic Malignancies 1 for the study of TBS-2025 in blood-related cancer treatment.
